Texas OAG Reaches $42.7 Million Settlement over Alleged Medicaid Fraud
The Texas OAG settled with six subsidiaries of Takeda Pharmaceutical Co. to resolve allegations that the companies committed Medicaid fraud in violation of the Texas Medicaid Fraud Prevention Act (TMFPA). According to the AG’s office, the settlement addresses alleged TMFPA violations raised by a whistleblower in a qui tam lawsuit. The lawsuit alleged that the…